+852-3069 6950
sales@gugent.com.hk
Catalog No. WATS-186004713
Part No. 186004713
Supplier Waters Corporation
Oasis Peptide Method Development 96 well µElution Plate, 2 mg, 30 µm, 1/pk
Net Price
351
Availability

In stock

RECOMMENDED PRODUCTS
PROPERTIES
  • Brand
    Oasis
  • Chemistry
    Method Development
  • Endcapped
    No
  • Format
    96-well µElution Plate
  • Mass Spec Compatibility
    Yes
  • Material
    Polypropylene
  • Mode
    Mixed mode
  • Number of Wells
    96
  • Particle Size
    30 µm
  • pH Range Max
    14 pH
  • pH Range Min
    0 pH
  • Pore Size
    80 Å
  • Product Type
    Solid Phase Extraction
  • Sorbent Substrate
    Copolymer
  • Sorbent Weight
    2 mg
  • Units per Package
    1 pk
  • UNSPSC
    41115712
  • Water Wettable
    Yes
DESCRIPTION
Oasis Peptide Method Development µElution Plate is designed to simplify the process of sample preparation for the analysis of therapeutic peptides in plasma. The 96-well plate format contains six rows each of two Oasis mixed-mode, ion-exchange chemistries: a strong exchanger (MAX) and a weak cation exchanger (WCX). Sample preparation method development can be quickly and easily achieved with the use of a single SPE protocol. The Oasis Peptide µElution Method Development Plate is sold separately or as a component of the UPLC Therapeutic Peptide Method Development Kit (176001835) and the HPLC Therapeutic Peptide Method Development Kit (176001836).
CUSTOMERS ALSO VIEWED